COVID-19 vaccine

With classes starting on Aug. 23, President Robert C. Robbins says vaccines are still our "best hope" against COVID-19.

Data shows that 67% of people with mild or moderate COVID-19 infection develop long COVID, with symptoms that last more than 30 days after a positive test.

A study that started by analyzing COVID-19 immunity and vaccine effectiveness in frontline workers is broadening to include children, thanks to a $15 million grant renewal from the Centers for Disease Control and Prevention.

People who contract COVID-19 even after vaccination are likely to have a lower viral load, experience a shorter infection time and have milder symptoms, new research finds.

A College of Medicine – Tucson assistant professor of pediatrics answers questions about COVID-19 vaccine effectiveness and the risk of side effects in children.

The university's COVID-19 vaccination POD has moved fully indoors and will continue to operate through June 25. Walk-ins are accepted at the Ina E. Gittings Building.